Also trades as: DBD.DE (XETRA) · $vol 0M · WIN.SW (SIX)

$66.68

-2.14 (-3.11%)

Weekly Expected Move ±4.2%

$63 $66 $69 $72 $75

NYSE · Technology · Software - Application · Tech Score Buy · Power 64 · $2.3B mcap · 29M float · 0.925% daily turnover · Short 81% of daily vol

Credit Risk of going bust: higher than 51% of companies Debt: 32.9% of company value Bonds: $214.9M held by 126 funds, 212 bp over Treasuries → details ▾

Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $2.33 (down 97%), Diebold Nixdorf, Incorporated would be worth roughly what it owes.
Total debt $1.11B against a stock market value of $2.26B.
Distance to default 5.03 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $527.5M (short-term plus half of long-term), stock volatility 40.1%; Altman Z'' 1.55. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE

37.0 / 100

NoneWeakNarrowWide

Primary source: Cost Advantage · ROIC: 12.6%

Cost Advantage ★

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. DBD has No discernible competitive edge (37.0/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. ROIC of 12.6% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

Low

$100

Avg Target

$100

High

Based on 2 analyst ratings (12 mo)

Analyst Recommendations

Strong Buy: 0Buy: 5Hold: 5Sell: 3Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$100.00

Analysts2

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-02-13	D.A. Davidson	Matt Summerville	$29	$100	+71	+23.2%	$81.19
2026-02-13	Wedbush	—	$70	$100	+30	+25.3%	$79.83
2025-08-07	Wedbush	Antoine Legault	$50	$70	+20	+16.7%	$60.00
2024-05-03	Wedbush	Matt Bryson	$5	$50	+45	+31.5%	$38.01
2023-11-10	D.A. Davidson	Matthew Summerville	$7	$29	+22	+36.7%	$21.21
2022-07-08	Wedbush	Matt Bryson	Initiated	$5	—	+64.5%	$3.04
2022-04-30	D.A. Davidson	Matt Summerville	Initiated	$7	—	+70.7%	$4.10

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

Oct 27, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. DBD receives an overall rating of B. Strongest factors: DCF (5/5). Areas of concern: ROA (2/5), D/E (1/5), P/E (2/5).

Rating Change History

Date	From	To
2026-10-01	B+	B
2026-08-10	B	B+
2026-07-01	B+	B
2026-05-18	A-	B+
2026-05-12	B+	A-
2026-04-24	B	B+
2026-03-23	B+	B
2026-03-09	B	B+
2026-02-24	C+	B
2026-01-03	B-	C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 54 Grade B

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. DBD scores highest in Momentum (88/100) and lowest in Profitability (24/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

2.07

Grey Zone

Piotroski F-Score

7/9

✓ ✓ ✓ ✓ ✗ ✗ ✓ ✓ ✓

Beneish M-Score

-2.62

Unlikely Manipulator

Ohlson O-Score

-6.68

Bankruptcy prob: 0.1%

Low Risk

Credit Rating

BB+

Score: 49.0/100

Trend: Improving

Earnings Quality

100/100

OCF/NI: 2.39x

Accruals: -4.1%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. DBD scores 2.07, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. DBD scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. DBD's score of -2.62 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. DBD's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. DBD receives an estimated rating of BB+ (score: 49.0/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). DBD's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

21.44x

PEG

0.02x

P/S

0.58x

P/B

2.37x

P/FCF

13.36x

P/OCF

11.30x

EV/EBITDA

10.27x

EV/Revenue

0.99x

EV/EBIT

15.43x

EV/FCF

17.04x

Earnings Yield

3.71%

FCF Yield

7.48%

Shareholder Yield

3.03%

Graham Number

$44.11

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 21.4x earnings, DBD commands a growth premium. Graham's intrinsic value formula yields $44.11 per share, 51% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.690

NI / EBT

Interest Burden

0.650

EBT / EBIT

EBIT Margin

0.064

EBIT / Rev

Asset Turnover

1.036

Rev / Assets

Equity Multiplier

3.618

Assets / Equity

ROE

10.8%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. DBD's ROE of 10.8% is driven by financial leverage (equity multiplier: 3.62x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

0.00%

Fair P/E

8.50x

Intrinsic Value

$26.78

Price/Value

3.18x

Margin of Safety

-217.52%

Premium

217.52%

Assessment

Overvalued

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with DBD's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. DBD trades at a 218% premium to its adjusted intrinsic value of $26.78, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 21.4x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 805 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$66.82

Median 1Y

$89.04

5th Pctile

$44.77

95th Pctile

$178.69

Ann. Volatility

40.6%

25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
OCTAVIO MARQUEZ Director, President and CEO	$850,000	$3,075,002	$8,694,401
THOMAS TIMKO EVP, Chief Financial Officer	$705,985	$1,058,380	$2,985,140
KATHLEEN CREECH EVP, er EVP, Chief People Officer	$471,138	$361,536	$2,795,509
JONATHAN MYERS EVP, Chief Revenue Officer	$567,169	$581,050	$2,454,959
FRANK BAUR EVP, Chief Operating Officer	$615,218	$422,839	$2,188,731
ILHAMI CANTADURUCU EVP, Global Retail	$510,453	$365,074	$1,932,117

CEO Pay Ratio

275:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $8,694,401

Avg Employee Cost (SGA/emp): $31,625

Employees: 20,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

20,000

-4.8% YoY

Revenue / Employee

$190,285

Rev: $3,805,700,000

Profit / Employee

$4,730

NI: $94,600,000

SGA / Employee

$31,625

Avg labor cost proxy

R&D / Employee

$4,335

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	2.2%	2.0%	2.1%	2.2%	0.0%	-1.7%	-1.0%	-1.2%	4.7%	9.3%	10.8%	10.8%	10.76%
ROA	53.3%	52.0%	54.5%	56.2%	0.0%	-0.4%	-0.3%	-0.3%	1.3%	2.6%	2.9%	3.0%	2.97%
ROIC	2.0%	4.8%	6.2%	9.8%	0.3%	-3.2%	-1.5%	-3.4%	8.0%	12.4%	14.0%	12.6%	12.56%
ROCE	1.9%	4.4%	5.9%	9.3%	8.9%	11.0%	10.0%	7.7%	8.8%	8.4%	9.5%	10.4%	10.39%
Gross Margin	22.5%	21.7%	23.3%	25.9%	25.5%	23.9%	24.1%	25.6%	26.2%	27.1%	25.3%	25.7%	25.74%
Operating Margin	4.0%	5.4%	2.7%	7.5%	5.0%	4.2%	3.5%	6.1%	7.8%	11.6%	6.5%	6.2%	6.17%
Net Margin	2.3%	2.2%	-1.6%	1.6%	-2.4%	0.6%	-1.0%	1.3%	4.3%	4.5%	0.6%	1.7%	1.67%
EBITDA Margin	9.0%	10.7%	7.0%	12.1%	8.5%	13.4%	5.7%	7.7%	11.1%	10.3%	7.4%	9.5%	9.48%
FCF Margin	-9.5%	3.4%	1.1%	0.4%	2.9%	3.7%	4.9%	5.7%	6.2%	6.5%	6.9%	5.8%	5.80%
OCF Margin	-8.7%	4.1%	2.0%	1.3%	3.0%	4.0%	5.1%	6.2%	7.6%	7.9%	8.2%	6.9%	6.86%
ROE 3Y Avg	snapshot only												75.82%
ROA 3Y Avg	snapshot only												19.62%
ROIC 3Y Avg	snapshot only												32.21%
ROIC Economic	snapshot only												11.27%
Cash ROA	snapshot only												7.11%
Cash ROIC	snapshot only												14.80%
CROIC	snapshot only												12.51%
NOPAT Margin	snapshot only												5.82%
Pretax Margin	snapshot only												4.16%
R&D / Revenue	snapshot only												2.17%
SGA / Revenue	snapshot only												12.15%
SBC / Revenue	snapshot only												0.27%

Valuation

Metric	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	0.33	0.50	0.60	0.67	8396.08	-98.08	-161.16	-161.05	42.27	26.05	24.96	26.99	21.441
P/S Ratio	0.75	0.55	0.45	0.38	0.44	0.43	0.44	0.57	0.58	0.65	0.70	0.78	0.585
P/B Ratio	0.73	1.02	1.28	1.46	1.57	1.74	1.67	1.89	1.93	2.24	2.63	3.10	2.367
P/FCF	-7.96	16.27	42.46	100.74	15.36	11.63	9.05	9.87	9.32	10.02	10.12	13.36	13.362
P/OCF	—	13.51	22.68	29.55	14.53	10.85	8.73	9.17	7.65	8.20	8.50	11.30	11.295
EV/EBITDA	18.57	9.60	8.13	6.08	6.87	6.06	6.39	8.64	8.23	9.57	9.63	10.27	10.273
EV/Revenue	1.67	0.95	0.73	0.59	0.66	0.63	0.64	0.78	0.79	0.85	0.89	0.99	0.989
EV/EBIT	31.54	15.71	14.10	9.72	10.89	9.39	10.14	14.96	13.59	15.40	14.87	15.43	15.434
EV/FCF	-17.64	28.14	68.99	157.33	23.03	16.90	13.12	13.52	12.75	13.10	12.83	17.04	17.042
Earnings Yield	3.0%	2.0%	1.7%	1.5%	0.0%	-1.0%	-0.6%	-0.6%	2.4%	3.8%	4.0%	3.7%	3.71%
FCF Yield	-12.6%	6.1%	2.4%	1.0%	6.5%	8.6%	11.1%	10.1%	10.7%	10.0%	9.9%	7.5%	7.48%
PEG Ratio	snapshot only												0.017
EV/OCF	snapshot only												14.406
EV/Gross Profit	snapshot only												3.781
Acquirers Multiple	snapshot only												12.090
Shareholder Yield	snapshot only												3.03%
Graham Number	snapshot only												$44.11

Leverage & Solvency

Metric	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	1.47	1.52	1.39	1.42	1.45	1.32	1.35	1.36	1.36	1.30	1.28	1.27	1.267
Quick Ratio	1.00	1.10	0.94	0.95	0.96	0.90	0.91	0.91	0.89	0.92	0.89	0.83	0.826
Debt/Equity	1.29	1.28	1.10	1.10	1.03	1.13	1.07	0.97	0.96	1.07	1.07	1.14	1.144
Net Debt/Equity	0.89	0.75	0.80	0.82	0.79	0.79	0.75	0.70	0.71	0.69	0.70	0.85	0.853
Debt/Assets	0.31	0.33	0.28	0.29	0.28	0.30	0.29	0.28	0.29	0.30	0.29	0.30	0.297
Debt/EBITDA	14.82	6.93	4.29	2.95	3.00	2.70	2.83	3.23	3.00	3.49	3.08	2.98	2.976
Net Debt/EBITDA	10.19	4.05	3.13	2.19	2.29	1.89	1.98	2.33	2.22	2.25	2.03	2.22	2.218
Interest Coverage	0.72	1.27	1.08	1.32	1.58	1.61	1.77	1.63	2.16	2.44	2.62	2.76	2.762
Equity Multiplier	4.12	3.91	3.89	3.86	3.66	3.81	3.68	3.41	3.36	3.50	3.74	3.86	3.855
Cash Ratio	snapshot only												0.209
Debt Service Coverage	snapshot only												4.149
Cash to Debt	snapshot only												0.255
FCF to Debt	snapshot only												0.203
Defensive Interval	snapshot only												490.3 days

Efficiency & Turnover

Metric	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.23	0.48	0.73	0.99	0.96	0.97	0.98	0.97	0.97	1.03	1.03	1.04	1.036
Inventory Turnover	1.10	2.62	3.51	4.63	4.41	5.06	4.67	4.58	4.46	5.38	5.15	4.89	4.889
Receivables Turnover	1.34	2.74	4.35	5.87	5.55	5.73	5.85	5.88	5.93	6.35	6.43	6.60	6.603
Payables Turnover	1.38	2.92	4.16	5.98	5.73	5.71	5.63	6.00	5.89	6.33	6.11	6.10	6.100
DSO	272	133	84	62	66	64	62	62	62	57	57	55	55.3 days
DIO	333	139	104	79	83	72	78	80	82	68	71	75	74.7 days
DPO	264	125	88	61	64	64	65	61	62	58	60	60	59.8 days
Cash Conversion Cycle	341	147	100	80	85	72	76	81	81	68	68	70	70.1 days
Fixed Asset Turnover	snapshot only												12.637
Operating Cycle	snapshot only												129.9 days
Cash Velocity	snapshot only												13.711
Capital Intensity	snapshot only												0.965

Growth (YoY)

Metric	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	—	—	—	—	3.0%	89.4%	28.6%	-3.7%	-2.9%	1.5%	4.3%	5.4%	5.44%
Net Income	—	—	—	—	-100.0%	-1.0%	-1.0%	-1.0%	252.0%	6.7%	11.6%	9.6%	9.62%
EPS	—	—	—	—	-100.0%	-1.0%	-1.0%	-1.0%	252.7%	6.9%	12.1%	10.2%	10.16%
FCF	—	—	—	—	2.2%	1.1%	5.0%	13.6%	1.1%	76.7%	46.4%	6.7%	6.70%
EBITDA	—	—	—	—	3.3%	97.9%	44.3%	-11.7%	-3.1%	-13.2%	-5.0%	13.1%	13.15%
Op. Income	—	—	—	—	4.3%	96.0%	61.0%	-7.5%	2.2%	57.7%	67.9%	82.6%	82.58%
OCF Growth	snapshot only												17.31%
Asset Growth	snapshot only												-0.09%
Equity Growth	snapshot only												-11.67%
Debt Growth	snapshot only												4.31%
Shares Change	snapshot only												-5.87%

Growth Quality

Metric	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	—	—	—	—	—	—	—	—	0.72	0.77	0.87	0.08	0.076
Earnings Stability	—	—	—	—	—	—	—	—	0.73	0.71	0.71	0.70	0.705
Margin Stability	—	—	—	—	—	—	—	—	0.95	0.92	0.92	0.94	0.942
Rev. Growth Consistency	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.00	0.00	1.00	1.00	0.50	0.500
Earn. Growth Consistency	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	0.500
FCF Positive Streak	0	0	0	0	0	1	1	1	1	1	1	1	1
Earnings Persistence	—	—	—	—	—	—	—	—	0.50	0.20	0.20	0.20	0.200
Earnings Smoothness	—	—	—	—	0.00	—	—	—	0.00	—	—	—	—
ROE Trend	—	—	—	—	—	—	—	—	-1.05	-0.92	-0.95	-0.97	-0.965
Gross Margin Trend	—	—	—	—	—	—	—	—	0.02	0.02	0.02	0.02	0.021
FCF Margin Trend	—	—	—	—	—	—	—	—	0.10	0.03	0.04	0.03	0.027
Sustainable Growth Rate	2.2%	2.0%	2.1%	2.2%	0.0%	—	—	—	4.7%	9.3%	10.8%	10.8%	10.76%
Internal Growth Rate	1.1%	1.1%	1.2%	1.3%	0.0%	—	—	—	1.3%	2.6%	3.0%	3.1%	3.07%

Cash Flow Quality

Metric	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	-0.04	0.04	0.03	0.02	578.00	-9.04	-18.47	-17.56	5.52	3.18	2.94	2.39	2.389
FCF/OCF	1.09	0.83	0.53	0.29	0.95	0.93	0.96	0.93	0.82	0.82	0.84	0.85	0.845
FCF/Net Income	snapshot only												2.020
OCF/EBITDA	snapshot only												0.713
CapEx/Revenue	0.8%	0.7%	0.9%	0.9%	0.2%	0.3%	0.2%	0.4%	1.4%	1.4%	1.3%	1.1%	1.06%
CapEx/Depreciation	snapshot only												0.330
Accruals Ratio	0.55	0.50	0.53	0.55	-0.03	-0.04	-0.05	-0.06	-0.06	-0.06	-0.06	-0.04	-0.041
Sloan Accruals	snapshot only												-0.061
Cash Flow Adequacy	snapshot only												6.465
Earnings Quality Score	snapshot only												1.000

Dividends & Buybacks

Metric	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	—	—	—	0.0%	0.0%	0.0%	0.0%	0.00%
FCF Payout Ratio	—	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Total Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	—	—	—	1.6%	1.4%	1.7%	81.8%	81.83%
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.6%	1.9%	3.7%	5.3%	6.7%	3.0%	3.03%
Net Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.6%	1.9%	3.7%	5.3%	6.7%	3.0%	3.03%
Total Shareholder Return	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.6%	1.9%	3.7%	5.3%	6.7%	3.0%	3.03%

DuPont Factors

Metric	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	0.96	0.96	0.96	0.95	0.00	-0.33	-0.18	-0.46	0.71	0.78	0.76	0.69	0.690
Interest Burden (EBT/EBIT)	44.47	18.76	14.95	9.77	0.27	0.20	0.24	0.15	0.33	0.58	0.62	0.65	0.650
EBIT Margin	0.05	0.06	0.05	0.06	0.06	0.07	0.06	0.05	0.06	0.05	0.06	0.06	0.064
Asset Turnover	0.23	0.48	0.73	0.99	0.96	0.97	0.98	0.97	0.97	1.03	1.03	1.04	1.036
Equity Multiplier	4.12	3.91	3.89	3.86	3.88	3.87	3.79	3.62	3.51	3.64	3.71	3.62	3.618

Per Share

Metric	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$57.02	$57.56	$57.17	$57.42	$0.01	$-0.44	$-0.27	$-0.34	$1.35	$2.61	$3.02	$3.15	$3.15
Book Value/Share	$26.00	$28.29	$26.94	$26.44	$28.36	$24.73	$26.17	$29.26	$29.53	$30.30	$28.65	$27.46	$28.39
Tangible Book/Share	$-13.42	$-11.70	$-12.00	$-11.63	$3.28	$-11.57	$-10.74	$-9.59	$-9.15	$-9.23	$-10.47	$-11.38	$-11.38
Revenue/Share	$25.11	$52.66	$76.48	$101.20	$101.04	$99.76	$98.32	$97.93	$98.41	$104.84	$108.02	$109.69	$112.56
FCF/Share	$-2.38	$1.78	$0.81	$0.38	$2.91	$3.70	$4.83	$5.61	$6.12	$6.78	$7.45	$6.36	$6.53
OCF/Share	$-2.18	$2.14	$1.52	$1.30	$3.07	$3.97	$5.01	$6.04	$7.45	$8.28	$8.87	$7.53	$7.72
Cash/Share	$10.45	$14.99	$8.01	$7.57	$6.98	$8.33	$8.37	$7.85	$7.47	$11.47	$10.46	$8.00	$8.21
EBITDA/Share	$2.26	$5.21	$6.88	$9.89	$9.75	$10.32	$9.93	$8.78	$9.48	$9.28	$9.93	$10.56	$10.56
Debt/Share	$33.49	$36.10	$29.53	$29.19	$29.27	$27.85	$28.06	$28.35	$28.46	$32.34	$30.63	$31.41	$31.41
Net Debt/Share	$23.04	$21.11	$21.52	$21.62	$22.29	$19.52	$19.69	$20.50	$21.00	$20.87	$20.17	$23.41	$23.41

Academic Models

Metric	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	2.066
Altman Z-Prime	snapshot only												2.320
Piotroski F-Score	2	3	3	3	6	6	5	4	6	6	8	7	7
Beneish M-Score	—	—	—	—	-2.71	-2.77	-2.88	-2.87	-2.75	-2.73	-2.75	-2.62	-2.615
Ohlson O-Score	snapshot only												-6.683
Net-Net WC	snapshot only												$-29.70
EVA	snapshot only												$45909478.91

Credit

Metric	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only												BB+
Credit Score	20.71	26.52	30.29	33.21	35.25	37.47	37.78	37.99	46.95	48.24	47.92	49.05	49.045
Credit Grade	snapshot only												11
Credit Trend	snapshot only												11.059
Implied Spread (bps)	snapshot only												400.000
Industry Credit Rank	snapshot only												39
Sector Credit Rank	snapshot only												32

DBD NYSE

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet